Stay up to date with notifications from The Independent

Notifications can be managed in browser preferences.

Indonesia revokes drug companies' licenses after 159 deaths

Indonesian authorities have revoked the licenses of two pharmaceutical companies to produce syrup-type medicines following the deaths of 159 children due to acute kidney injury

Edna Tarigan
Tuesday 01 November 2022 08:17 EDT
Indonesia Children Deaths
Indonesia Children Deaths (Copyright 2022 The Associated Press. All rights reserved.)

Your support helps us to tell the story

From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or producing our latest documentary, 'The A Word', which shines a light on the American women fighting for reproductive rights, we know how important it is to parse out the facts from the messaging.

At such a critical moment in US history, we need reporters on the ground. Your donation allows us to keep sending journalists to speak to both sides of the story.

The Independent is trusted by Americans across the entire political spectrum. And unlike many other quality news outlets, we choose not to lock Americans out of our reporting and analysis with paywalls. We believe quality journalism should be available to everyone, paid for by those who can afford it.

Your support makes all the difference.

Indonesian authorities have revoked the licenses of two pharmaceutical companies to produce syrup-type medicines following the deaths of 159 children due to acute kidney injury, officials said Tuesday.

Penny Lukito, chief of the Food and Drug Monitoring Agency, known as BPOM, said it found that PT Yarindo Farmatama and PT Universal Pharmaceutical Industries had changed suppliers of propylene glycol, a component of the syrups, and the type they were using was contaminated with other chemicals.

“If there is a change, it should be reported to BPOM," Lukito said. In cases of non-compliance, pharmaceutical companies are "subject to administrative sanctions in the form of cessation of production, distribution, recall and destruction,” Lukito said.

The agency and the National Police found that the two companies used propylene glycol as a raw material in the production of medicinal syrups. The syrups, often used by children, contained excessive amounts of ethylene glycol and diethylene glycol. The findings were based on interviews with employees and an examination of documents, facilities and products of the companies.

The two chemicals are often used in industrial applications and in antifreeze and brake fluids.

Lukito said BPOM is pursuing criminal charges against the companies.

“Perpetrators face a maximum prison sentence of 10 years and a maximum fine of 1 billion rupiah ($64,000),” Lukito said.

The contamination is suspected of being the cause of a spike in cases of acute kidney disorders in children since the end of August.

The Health Ministry reported on Tuesday that there have been 304 cases of acute kidney injury in 27 provinces. Most of the patients were under age 5. The ministry said it has distributed 146 vials of antidotes to 17 hospitals across the country.

Ministry spokesperson Mohammad Syahril said the number of new cases and deaths has decreased since the government announced a temporary ban on the use of syrup medicines until the completion of its investigation.

Thank you for registering

Please refresh the page or navigate to another page on the site to be automatically logged inPlease refresh your browser to be logged in